Document Type : Systematic Review
Author
Clinical Research Development Unit (FACRDU), Department of geriatrician, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
10.22034/mphrj.2026.612969.1139
Abstract
Autoimmune thyroid diseases (AITDs), principally Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), have increasingly been associated with neurocognitive abnormalities, including impaired memory, attention, executive functioning, processing speed, and affective regulation. Although thyroid hormone disturbances provide an established biological explanation for several neurological manifestations, cognitive complaints may persist in euthyroid patients, suggesting additional contributions from autoimmune and neuroinflammatory mechanisms. This systematic review examines the relative and potentially interacting contributions of thyroid hormone status, thyroid autoimmunity, and neuroinflammation to neurocognitive dysfunction in AITDs. Relevant clinical, epidemiological, neuropsychological, neuroimaging, and mechanistic literature was examined using a structured evidence-synthesis framework. Particular attention was given to studies assessing cognitive performance in patients with overt or subclinical thyroid dysfunction, euthyroid autoimmune thyroiditis, and autoimmune-associated encephalopathic presentations. The evidence indicates that thyroid hormone abnormalities can adversely affect cerebral metabolism, synaptic function, and cognitive performance, particularly in attention and memory domains. However, findings concerning subclinical hypothyroidism and long-term cognitive outcomes remain inconsistent. Independent associations between thyroid autoimmunity and cognitive complaints have also been reported, although thyroid peroxidase antibodies cannot be considered direct evidence of pathogenic central nervous system autoimmunity. Neuroinflammatory pathways, including cytokine signaling, altered immune regulation, and potential blood–brain barrier dysfunction, provide biologically plausible explanations for persistent symptoms despite biochemical euthyroidism. Severe neurological manifestations, including steroid-responsive encephalopathy associated with autoimmune thyroiditis, represent a distinct clinical spectrum and should not be conflated with nonspecific cognitive complaints. Overall, neurocognitive dysfunction in AITDs appears multifactorial rather than exclusively hormone-dependent. Future longitudinal studies integrating standardized neuropsychological assessments, thyroid biomarkers, inflammatory profiles, and neuroimaging are necessary to establish causal pathways and identify clinically meaningful subgroups.
Keywords
Subjects